Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Treat-to-target dose titration scheme (individually adjusted dose) for a once daily injection s.c. (under the skin)

DRUG

insulin aspart

Administered 1 - 3 times daily, at largest prandial increment, injection s.c. (under the skin)

DRUG

insulin aspart

Administered 1 - 3 times daily, at largest meals, injection s.c. (under the skin)

Trial Locations (69)

1702

Novo Nordisk Investigational Site, Sarpsborg

1818

Novo Nordisk Investigational Site, Johannesburg

1829

Novo Nordisk Investigational Site, Johannesburg

2050

Novo Nordisk Investigational Site, Jessheim

3116

Novo Nordisk Investigational Site, Tønsberg

4011

Novo Nordisk Investigational Site, Stavanger

8000

Novo Nordisk Investigational Site, Århus C

9038

Novo Nordisk Investigational Site, Tromsø

10004

Novo Nordisk Investigational Site, Cáceres

11000

Novo Nordisk Investigational Site, Belgrade

11108

Novo Nordisk Investigational Site, Narbonne

15706

Novo Nordisk Investigational Site, Santiago de Compostela

18000

Novo Nordisk Investigational Site, Nis

23294

Novo Nordisk Investigational Site, Richmond

23606

Novo Nordisk Investigational Site, Newport News

28034

Novo Nordisk Investigational Site, Madrid

28803

Novo Nordisk Investigational Site, Asheville

28935

Novo Nordisk Investigational Site, Mostoles - Madrid -

29010

Novo Nordisk Investigational Site, Málaga

29651

Novo Nordisk Investigational Site, Greer

30318

Novo Nordisk Investigational Site, Atlanta

30606

Novo Nordisk Investigational Site, Athens

33100

Novo Nordisk Investigational Site, Tampere

33136

Novo Nordisk Investigational Site, Miami

37411

Novo Nordisk Investigational Site, Chattanooga

45429

Novo Nordisk Investigational Site, Kettering

45439

Novo Nordisk Investigational Site, Dayton

53209

Novo Nordisk Investigational Site, Milwaukee

69200

Novo Nordisk Investigational Site, Vénissieux

71200

Novo Nordisk Investigational Site, Le Creusot

75230

Novo Nordisk Investigational Site, Dallas

75231

Novo Nordisk Investigational Site, Dallas

77030

Novo Nordisk Investigational Site, Houston

78229

Novo Nordisk Investigational Site, San Antonio

92014

Novo Nordisk Investigational Site, Nanterre

92691

Novo Nordisk Investigational Site, Mission Viejo

93720

Novo Nordisk Investigational Site, Fresno

97159

Novo Nordisk Investigational Site, Pointe à Pitre

119435

Novo Nordisk Investigational Site, Moscow

123448

Novo Nordisk Investigational Site, Moscow

127644

Novo Nordisk Investigational Site, Moscow

50314-3027

Novo Nordisk Investigational Site, Des Moines

08648

Novo Nordisk Investigational Site, Lawrenceville

75390-9302

Novo Nordisk Investigational Site, Dallas

FI-02650

Novo Nordisk Investigational Site, Espoo

FI-90100

Novo Nordisk Investigational Site, Oulu

FI-90220

Novo Nordisk Investigational Site, Oulu

FIN-61500

Novo Nordisk Investigational Site, Vaasa

FI-01620

Novo Nordisk Investigational Site, Vantaa

5216 GC

Novo Nordisk Investigational Site, 's-Hertogenbosch

5631 BM

Novo Nordisk Investigational Site, Eindhoven

4872 LP

Novo Nordisk Investigational Site, Etten-Leur

4561 NV

Novo Nordisk Investigational Site, Hulst

3563 AZ

Novo Nordisk Investigational Site, Utrecht

3443 GG

Novo Nordisk Investigational Site, Woerden

0160

Novo Nordisk Investigational Site, Oslo

0001

Novo Nordisk Investigational Site, Pretoria

07300

Novo Nordisk Investigational Site, Inca

06800

Novo Nordisk Investigational Site, Mérida

262 91

Novo Nordisk Investigational Site, Ängelholm

417 17

Novo Nordisk Investigational Site, Gothenburg

431 80

Novo Nordisk Investigational Site, Mölndal

AB25 1LD

Novo Nordisk Investigational Site, Aberdeen

CV2 2DX

Novo Nordisk Investigational Site, Coventry

EH54 6PP

Novo Nordisk Investigational Site, Livingstone

SA14 8QF

Novo Nordisk Investigational Site, Llanelli

CF72 8XR

Novo Nordisk Investigational Site, Llantrisant

RG7 3SQ

Novo Nordisk Investigational Site, Reading

CV22 5PX

Novo Nordisk Investigational Site, Rugby

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00537303 - Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes | Biotech Hunter | Biotech Hunter